Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by okgonowon Oct 02, 2023 1:12pm
88 Views
Post# 35665261

RE:And it begins…return of B2B…

RE:And it begins…return of B2B…
alleyesonme wrote: $500,000 supply agreement to provide Tilray with MediPharm products and services over four-years.....small but very significant...tilray has an appetite for third party manufacturing...excellent cost control measure...could lead to huge contract.

If  LABS manufacturing capabilities are so specialized (pharma grade) and propriatary then LABS would be in the drivers seat when it comes to any contract because they are the only game in town ?

also if all that is said to become reality in tearms of producing for the Phama industry then woud LABS even have the capacity to do anything other than to produce for anyone else other than Pharma... i would think margin is much higher on a FDA,HC, etc. aproved product ??

Tillray is a big player in the rec weed space (looks like they are going for something else with these recent aquisitions in the US they dont need LABS specialized production methods ?
<< Previous
Bullboard Posts
Next >>